Promoter histone H3 lysine 9 di-methylation is associated with DNA methylation and aberrant expression of p16 in gastric cancer cells

Oncology Reports

Volumn 22, Issue 5, 2009, Pages 1221-1227

  Meng, Chun Feng ^a   Zhu, Xin Jiang ^a   Peng, Guo ^a   Dai, Dong Qiu ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

DNA methylation; Gastric cancer; Gene expression; Histone H3 lysine 9 acetylation; Histone H3 lysine 9 methylation; P16

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; HISTONE H3; HISTONE H3 LYSINE 9; PROTEIN P16; TRICHOSTATIN A; UNCLASSIFIED DRUG;

ACETYLATION; ARTICLE; CANCER CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEMETHYLATION; DNA METHYLATION; DNA MODIFICATION; DRUG POTENTIATION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE SILENCING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; STOMACH CANCER; TUMOR SUPPRESSOR GENE;

ACETYLATION; AZACITIDINE; BLOTTING, WESTERN; CHROMATIN IMMUNOPRECIPITATION; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; DNA MODIFICATION METHYLASES; DNA, NEOPLASM; ENZYME INHIBITORS; GENE SILENCING; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; HISTONES; HUMANS; HYDROXAMIC ACIDS; IMMUNOPRECIPITATION; LYSINE; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 70449397576     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000558     Document Type: Article

References (38)

1. Feinberg AP and Tycko B: The history of cancer epigenetics. Nat Rev Cancer 4: 143-153, 2004.
2. Serrano M, Hannon GJ and Beach D: A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366: 704-707, 1993.
3. Takaoka AS, Kakiuchi H, Itoh F, et al: Infrequent alterations of the p16 (MTS-1) gene in human gastric cancer. Tumor Biol 18: 95-103, 1997.
4. Gunther T, Schneider-Stock R, Pross M, et al: Alteration of p16/ MTS1-tumor suppressor gene in gastric cancer. Pathol Res Pract 194: 809-813, 1998.
5. Lee YY, Kang SH, Seo JY, et al: Alterations of p16INK4A and p15INK4B genes in GC. Cancer (Phila) 80: 1889-1896, 1997.
6. Suzuki H, Itoh F, Toyota M, et al: Distinct methylation pattern and microsatellite instability in sporadic gastric cancer. Int J Cancer 83: 309-313, 1999.
7. Shim YH, Kang GH and Ro JY: Correlation of p16 hypermethylation with p16 protein loss in sporadic gastric carcinomas. Lab Invest 80: 689-695, 2000.
8. Jaenisch R and Bird A: Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 33: S245-S254, 2003.
9. Tamaru H and Selker EU: A histone H3 methyltransferase controls DNA methylation in Neurospora crassa. Nature 414: 277-283, 2001.
10. Jackson JP, Lindroth AM, Cao X and Jacobsen SE: Control of CpNpG DNA methylation by the KRYPTONITE histone H3 methyltransferase. Nature 416: 556-560, 2002.
11. Lehnertz B, Ueda Y, Derijck AA, et al: Suv39h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin. Curr Biol 13: 1192-1200, 2003.
12. Tariq M, Saze H, Probst AV, Lichota J, Habu Y and Paszkowski J: Erasure of CpG methylation in arabidopsis alters patterns of histone H3 methylation in heterochromatin. Proc Natl Acad Sci USA 100: 8823-8827, 2003.
13. Espada J, Ballestar E, Fraga MF, et al: Human DNA methyltransferase 1 is required for maintenance of the histone H3 modification pattern. J Biol Chem 279: 37175-37184, 2004.
14. Xiao Q, Li L, Xie Y, et al: Transcription factor E2F-1 is upregulated in human gastric cancer tissues and its overexpression suppresses stomach tumor cell proliferation. Cell Oncol 29: 335-349, 2007.
15. Zhang Q, Nie M, Sham J, et al: Effective gene-viral therapy for telomerase-positive cancers by selective replicative-competent adenovirus combining with endostatin gene. Cancer Res 64: 5390-5397, 2004.
16. Yu HG, Ai YW, Yu LL, et al: Phosphoinositide 3-kinase/Akt pathway plays an important role in chemoresistance of gastric cancer cells against etoposide and doxorubicin induced cell death. Int J Cancer 122: 433-443, 2008.
17. Fahrner JA, Eguchi S, Herman JG and Baylin SB: Dependence of histone modifications and gene expression on DNA hypermethylation in cancer. Cancer Res 62: 7213-7218, 2002.
18. Kondo Y, Shen L and Issa JP: Critical role of histone methylation in tumor suppressor gene silencing in colorectal cancer. Mol Cell Biol 23: 206-215, 2003.
19. Cameron EE, Bachman KE, Myohanen S, Herman JG and Baylin SB: Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet 21: 103-107, 1999.
20. Herman JG, Graff JR, Myohanen S, Nelkin BD and Baylin SB: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93: 9821-9826, 1996.
21. Yang SH and Dai DQ: Analysis and improvement of methylation-specific polymerase chain reaction. Cancer Res Clin (in Chinese) 18: 594-595, 2006.
22. Kuo MH and Allis CD: In vivo cross-linking and immunoprecipitation for studying dynamic protein: DNA associations in a chromatin environment. Methods 19: 425-433, 1999.
23. Li Y, Zhao Y, Li G, et al: Regulation of neuronal nitric oxide synthase exon 1f gene expression by nuclear factor-jB acetylation in human neuroblastoma cells. J Neurochem 101: 1194-1204, 2007.
24. Pogribny IP, Ross SA, Tryndyak VP, Pogribna M, Poirier LA and Karpinets TV: Histone H3 lysine 9 and H4 lysine 20 trimethylation and the expression of Suv4-20h2 and Suv-39h1 histone methyltransferases in hepatocarcinogenesis induced by methyl deficiency in rats. Carcinogenesis 27: 1180-1186, 2006.
25. Kim JS and Shukl SD: Histone h3 modifications in rat hepatic stellate cells by ethanol. Alcohol Alcoholism 40: 367-372, 2005.
26. Coombes MM, Briggs KL, Bone JR, Clayman GL, El-Naggar AK and Dent SY: Resetting the histone code at CDKN2A in HNSCC by inhibition of DNA methylation. Oncogene 22: 8902-8911, 2003.
27. Magdinier F and Wolffe AP: Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia. Proc Natl Acad Sci USA 98: 4990-4995, 2001.
28. Nguyen CT, Weisenberger DJ, Velicescu M, et al: Histone H3-lysine 9 methylation is associated with aberrant gene silencing in cancer cells and is rapidly reversed by 5-aza-2′-deoxycytidine. Cancer Res 62: 6456-6461, 2002.
29. Zhu WG, Dai Z, Ding H, et al: Increased expression of unmethylated CDKN2D by 5-aza-2′-deoxycytidine in human lung cancer cells. Oncogene 20: 7787-7796, 2001.
30. Coffee B, Zhang F, Warren ST and Reines D: Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells. Nat Genet 22: 98-101, 1999.
31. Osta El, Kantharidis AP, Zalcberg JR and Wolffe AP: Precipitous release of methyl-CpG binding protein 2 and histone deacetylase 1 from the methylated human multidrug resistance gene (MDR1) on activation. Mol Cell Biol 22: 1844-1857, 2002.
32. Ghoshal K, Datta J, Majumder S, et al: Inhibitors of histone deacetylase and DNA methyltransferase synergistically activate the methylated metallothionein I promoter by activating the transcription factor MTF-1 and forming an open chromatin structure. Mol Cell Biol 22: 8302-8319, 2002.
33. Guan ZY, Dai DQ and Meng CF: Experimental studies on 5-aza-2′-deoxycytidine induction for demethylation and up-regulated transcription of human gastric cancer cell lines TIMP3 Gene. Chin J Clin Oncol (in Chinese) 33: 1334-1337, 2006.
34. McGarvey KM, Fahrner JA, Greene E, Martens J, Jenuwein T and Baylin SB: Silenced tumor suppressor genes reactivated by DNA demethylation do not return to a fully euchromatic chromatin state. Cancer Res 66: 3541-3549, 2006.
35. Fuks F, Burgers WA, Brehm A, Hughes-Davies L and Kouzarides T: DNA methyltransferase DNMT1 associates with histone deacetylase activity. Nat Genet 24: 88-91, 2000.
36. Rountree MR, Bachman KE and Baylin SB: DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci. Nat Genet 25: 269-277, 2000.
37. Nguyen C, Liang G, Nguyen TT, et al: Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells. J Natl Cancer Inst (Bethesda) 93: 1465-1472, 2001.
38. Jones PA: The DNA methylation paradox. Trends Genet 15: 34-37, 1999.